SCHEMBL305352

SCHEMBL305352

[CH2]C(C)C(CC)CCCC(C)(CC)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10814733 0.77 CYP3A4 (0.37)
SCHEMBL1974135 0.74 ALDH1A1 (0.37)
SCHEMBL27448231 0.72 ALDH1A1 (0.36)
SCHEMBL1971485 0.72 OPRM1 (0.44)
SCHEMBL28361753 0.70 OPRM1 (0.42)
SCHEMBL28277593 0.70 OPRM1 (0.42)
SCHEMBL28153724 0.70 OPRM1 (0.42)
SCHEMBL1968956 0.70 OPRM1 (0.42)
SCHEMBL28271638 0.70 OPRM1 (0.42)
SCHEMBL28154751 0.70 OPRM1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114008028-B Pyrimidine derivative for inhibiting growth of cancer cells and medical application thereof 昂科比克斯有限公司 2024-07-09 CN disclosed
CN-114746432-B Transition metal compound, catalyst composition comprising the same, and process for producing olefin polymer using the catalyst composition 沙特基础工业爱思开NEXLENE私人有限公司 2024-06-21 CN disclosed
CN-117881678-A Compound with SHP2 protein degradation activity and medical application thereof 尤比克斯治疗公司 2024-04-12 CN disclosed
CN-117700420-A Fused tetracyclic compound, preparation method thereof and application thereof in medicines 江苏恒瑞医药股份有限公司 2024-03-15 CN disclosed
CN-117597341-A Sulfonamide derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-02-23 CN disclosed
CN-117597352-A Method for producing micrococcum-based carboxylic acid compound and micrococcum-based carboxylic acid compound produced thereby A&J科学有限公司 2024-02-23 CN disclosed
CN-117229284-A Tricyclic fused heterocyclic compound, preparation method and application thereof in medicine 上海泽德曼医药科技有限公司 2023-12-15 CN disclosed
CN-116785449-A Benzopyrrolopyrrole heterocyclic compound and conjugate thereof, preparation method and application thereof 江苏恒瑞医药股份有限公司 2023-09-22 CN disclosed
CN-116685323-A Purinone derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-09-01 CN disclosed
CN-113929618-B Oxo-pyridine amide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-08-11 CN disclosed
WO-2005035500-A2 THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN EURO-CELTIQUE S.A. (LU) 2005-04-21 WO disclosed
US-6864261-B2 Therapeutic agents useful for treating pain EURO-CELTIQUE S.A. (LU) 2005-03-08 US disclosed
WO-2005019353-A2 COPOLYMER SURFACTANTS COLUMBIA INSURANCE COMPANY (US) 2005-03-03 WO disclosed
US-20050039635-A1 Copolymer surfactants BENJAMIN MOORE & CO. 2005-02-24 US disclosed
US-20050025741-A1 Copolymers with (meth)acrylamides; improved separation of polynucleotides APPLIED BIOSYSTEMS, LLC 2005-02-03 US disclosed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO disclosed
US-20040127501-A1 Therapeutic agents useful for treating pain EURO-CELTIQUE S.A. (LU) 2004-07-01 US disclosed
WO-2004029044-A1 PYRIMIDINE COMPOUNDS AS THERAPEUTIC AGENTS EURO-CELTIQUE, S.A. (LU) 2004-04-08 WO disclosed
US-20040053914-A1 Therapeutic agents useful for treating pain PURDUE PHARMA L.P. 2004-03-18 US disclosed
WO-2003093236-A1 1-(PYRID-2-YL)-PIPERAZINE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR INHIBITOR EURO-CELTIQUE, S.A. (LU) 2003-11-13 WO disclosed